BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19246226)

  • 1. The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes.
    Möllsten A; Lajer M; Jorsal A; Tarnow L
    Mol Genet Metab; 2009 May; 97(1):80-4. PubMed ID: 19246226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy.
    Möllsten A; Wessman M; Svensson M; Forsblom C; Parkkonen M; Brismar K; Groop PH; Dahlquist G
    Ann Med; 2006; 38(7):522-8. PubMed ID: 17101543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes.
    Möllsten A; Jorsal A; Lajer M; Vionnet N; Tarnow L
    Diabetologia; 2009 Dec; 52(12):2590-3. PubMed ID: 19834686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism.
    Zanchi A; Moczulski DK; Hanna LS; Wantman M; Warram JH; Krolewski AS
    Kidney Int; 2000 Feb; 57(2):405-13. PubMed ID: 10652017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOS3 894G>T polymorphism is associated with progression of kidney disease and cardiovascular morbidity in type 2 diabetic patients: NOS3 as a modifier gene for diabetic nephropathy?
    Kuricová K; Tanhäuserová V; Pácal L; Bartáková V; Brožová L; Jarkovský J; Kaňková K
    Kidney Blood Press Res; 2013; 38(1):92-8. PubMed ID: 24603156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population.
    Chen F; Li YM; Yang LQ; Zhong CG; Zhuang ZX
    IUBMB Life; 2016 Jul; 68(7):516-25. PubMed ID: 27192959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients.
    El-Din Bessa SS; Hamdy SM
    Ren Fail; 2011; 33(9):878-84. PubMed ID: 21854353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in nitric oxide synthase 3 gene and implications for kidney disease: a meta-analysis.
    McKnight AJ; Patterson CC; Sandholm N; Kilner J; Buckham TA; Parkkonen M; Forsblom C; Sadlier DM; Groop PH; Maxwell AP;
    Am J Nephrol; 2010; 32(5):476-81. PubMed ID: 20962522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of catalase gene promoter in Romanian patients with diabetic kidney disease and type 1 diabetes.
    Panduru NM; Moţa E; Moţa M; Cimponeriu D; Serafinceanu C; Cheţa DM
    Rom J Intern Med; 2010; 48(1):81-8. PubMed ID: 21180245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
    Patente TA; Mohammedi K; Bellili-Muñoz N; Driss F; Sanchez M; Fumeron F; Roussel R; Hadjadj S; Corrêa-Giannella ML; Marre M; Velho G
    Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide synthase gene polymorphisms and diabetic nephropathy.
    Rippin JD; Patel A; Belyaev ND; Gill GV; Barnett AH; Bain SC
    Diabetologia; 2003 Mar; 46(3):426-8. PubMed ID: 12687343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.
    Lajer M; Tarnow L; Jorsal A; Parving HH
    Nephrol Dial Transplant; 2007 Nov; 22(11):3235-9. PubMed ID: 17567649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy.
    Möllsten A; Marklund SL; Wessman M; Svensson M; Forsblom C; Parkkonen M; Brismar K; Groop PH; Dahlquist G
    Diabetes; 2007 Jan; 56(1):265-9. PubMed ID: 17192491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
    Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
    Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of +35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes.
    Panduru NM; Cimponeriu D; Cruce M; Ion DA; Moţa E; Moţa M; Serafinceanu C; Chivu LI; Panduru M; Chivu RD; Covic AC
    Rom J Morphol Embryol; 2010; 51(1):37-41. PubMed ID: 20191117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women.
    Möllsten A; Vionnet N; Forsblom C; Parkkonen M; Tarnow L; Hadjadj S; Marre M; Parving HH; Groop PH
    Mol Genet Metab; 2011 May; 103(1):66-70. PubMed ID: 21316998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Mohamed MB; Mahjoub T; Kacem M; Almawi WY
    J Diabetes Complications; 2008; 22(5):331-8. PubMed ID: 18413207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
    Hyvönen ME; Ihalmo P; Sandholm N; Stavarachi M; Forsblom C; McKnight AJ; Lajer M; Maestroni A; Lewis G; Tarnow L; Maestroni S; Zerbini G; Parving HH; Maxwell AP; Groop PH; Lehtonen S
    Acta Diabetol; 2013 Dec; 50(6):887-97. PubMed ID: 23681557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.